Alto Neuroscience
ANRO· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Amit Etkin, M.D., Ph.D. is the CEO of Alto Neuroscience and was paid $2.2M in FY2025 (Dec), down 46%.
PayNo stock prices for these years
Executives3
See all- 1Amit Etkin, M.D., Ph.D.President, Chief Executive Officer, and Chair of the BoardFY2025
- 2Nicholas SmithChief Financial Officer and Chief Business OfficerFY2025
- 3Michael HanleyChief Operating OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAlto Neuroscience paid its 3 named executives $4.9M in total in FY2025 (Dec). CEO Amit Etkin, M.D., Ph.D. was paid $2.2M of that.
| Name | |||
|---|---|---|---|
| Amit Etkin, M.D., Ph.D.President, Chief Executive Officer, and Chair of the Board | |||
| Nicholas SmithChief Financial Officer and Chief Business Officer | |||
| Michael HanleyChief Operating Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Alto Neuroscience. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board3
See all- Christopher Nixon CoxLead independent director · 3 yr on the boardIndependentAudit, Compensation and Management Development (Chair), Nominating and Corporate Governance—Paid as an executive
- Andrew DreyfusDirector · 2 yr on the boardIndependentAudit, Compensation and Management Development—Paid as an executive
- Husseini Manji, M.D.Director · 1 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings5
See all| Proxy statement | DEF 14A | Mar 26, 2026 | FY2025 |
| Annual report | 10-K | Mar 16, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 1, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
| Annual report | 10-K | Mar 21, 2024 | FY2023 |
